The global assisted reproductive technology market was valued at USD 21.32 billion in 2018 and is expected to reach USD 45.06 billion by 2026, growing at a CAGR of 9.8%. The U.S. is experiencing significant market growth, driven by rising infertility rates, advancements in medical technologies, and increased awareness of reproductive treatments. In 2018, Europe led the global market with a share of 41.18%.

Assisted reproductive technologies (ART), encompassing procedures like in-vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo transfer (FET), and gamete intrafallopian transfer (GIFT), are increasingly sought after to address infertility issues. The growing prevalence of infertility, influenced by factors such as lifestyle changes, stress, and delayed childbearing, has heightened the demand for ART. Advancements in techniques like intracytoplasmic sperm injection (ICSI) and FET have further improved clinical outcomes, contributing to market growth. However, the widespread adoption of ART faces challenges. High treatment costs remain a significant barrier, particularly in emerging countries where affordability is a concern. Socio-ethical considerations and limited awareness also hinder accessibility. Despite these obstacles, supportive government initiatives and increasing awareness are gradually enhancing the accessibility and acceptance of ART services globally.

Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/assisted-reproductive-technology-art-market-101811

Assisted Reproductive Technology Market Trends:

The increasing prevalence of infertility in countries such as China, the U.S., the U.K., and India is driving the demand for assisted reproductive technologies (ART). In the U.S., approximately 6.7% of women aged 15–44 experienced infertility in 2018, with male infertility also on the rise. Contributing factors include sedentary lifestyles, stress, and obesity. To address this issue, governments and non-profit organizations in both developed and emerging nations are working to make fertility treatments more affordable, thereby further stimulating market growth.

List Of Top Assisted Reproductive Technology Market Companies:

• Bloom IVF Centre
• California Cryobank
• CARE Fertility
• Monash IVF Group
• Carolinas Fertility Institute
• European Sperm Bank
• INVO Bioscience
• Apollo Hospitals Enterprise Ltd.
• Other Players

Assisted Reproductive Technology Market Segmentation:

By Technique Outlook

In 2018, in vitro fertilization (IVF) led the assisted reproductive technology (ART) market, driven by its high success rates and continuous technological advancements, such as time-lapse imaging systems that monitor embryo development. These innovations are expected to further enhance IVF adoption. Frozen embryo transfer (FET) held the second-largest market share, offering a cost-effective option with high success rates and quicker results compared to fresh IVF cycles. Other techniques, including gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT), are also gaining traction due to their proven effectiveness.

By Procedure Outlook

The fresh non-donor procedure is projected to experience the highest compound annual growth rate (CAGR), attributed to its high success rates and the increasing prevalence of infertility. Studies indicate a 19% live birth rate for fresh egg-based fertility cycles. The frozen non-donor procedure, known for its affordability, holds the second-largest market share. Additionally, fresh donor and frozen donor procedures are anticipated to witness significant growth, supported by advancements in cryopreservation techniques and the growing acceptance of donor-assisted treatments.

By End-User Outlook

Fertility clinics dominated the ART market in 2018 and are expected to maintain this position, owing to the increasing number of specialized procedures and medical professionals in these settings. This segment is projected to grow rapidly, particularly in emerging economies like China, Japan, and India, where the demand for ART services is rising. Conversely, hospitals accounted for a smaller market share, with slower growth attributed to the limited adoption of advanced techniques and less comprehensive patient services.

Assisted Reproductive Technology Market Regional Analysis:

Europe led the assisted reproductive technology (ART) market in 2018, generating approximately USD 8.78 billion in revenue. This dominance is attributed to the high demand for ART procedures in countries such as Spain, Denmark, the U.K., Germany, and France. The region's advanced healthcare infrastructure and supportive regulatory environment further bolster its leading position.

North America is anticipated to witness significant growth, driven by increasing adoption of fertility services and higher disposable incomes, particularly in the United States. The presence of numerous fertility clinics and ongoing technological advancements contribute to the region's expanding market share.

The Asia Pacific region is projected to experience the highest growth rate by 2026. Factors such as the rising prevalence of infertility, growing awareness of ART procedures, and diminishing socio-ethical stigmas, especially in countries like India, China, Australia, and Japan, are propelling market expansion. Additionally, improvements in healthcare infrastructure and increasing medical tourism in the region support this upward trend.

Latin America and the Middle East & Africa are also expected to exhibit moderate growth. Enhancements in healthcare systems, coupled with rising infertility rates and greater acceptance of ART procedures, are contributing to the gradual development of these markets.

Key Industry Development:

In April 2019, Silverfleet Capital Partners acquired a significant stake in CARE Fertility to diversify its product portfolio and enhance its market position.